Trial record 11 of 32 for:    sinovac | China

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02692599
Recruitment Status : Completed
First Posted : February 26, 2016
Last Update Posted : October 26, 2017
Information provided by (Responsible Party):
Sinovac (Dalian) Vaccine Technology Co., Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2016
  Actual Study Completion Date : July 15, 2016